Abstract

BackgroundGlucocorticoid (GC) treatment has variable effect in sepsis. This may be explained by decreased expression or function of the glucocorticoid receptor (GR). The aim of this study was to determine GR expression and binding capacity in patients during and after sepsis.MethodsIn this prospective, non-interventional clinical study, peripheral blood and clinical data were collected from 20 adult patients at five timepoints during sepsis and 5–13 months after recovery. GR expression and binding capacity were assessed by flow cytometry.ResultsGR expression was higher in T lymphocytes from patients with septic shock compared to healthy subjects (p = 0.01). While there was no difference in GR expression between GC-treated and non-treated patients, GR binding capacity was lower in GC-treated patients at admission compared to healthy subjects (p ≤ 0.03). After the acute inflammation inflammatory phase, GR binding capacity was still lower in neutrophils of GC-treated patients, compared to healthy subjects (p = 0.01). On admission, GR binding capacity in T lymphocytes and neutrophils was inversely correlated with noradrenaline dose and lactate (p ≤ 0.03).ConclusionsOur data suggest that GR expression is increased in T lymphocytes during septic shock regardless of GC treatment, while GR binding capacity is decreased in neutrophils in GC-treated patients. As neutrophils are the predominant circulating leucocyte in septic shock, their decreased GR binding capacity may impede the response to exogenous or endogenous glucocorticoids.

Highlights

  • Glucocorticoid (GC) treatment has variable effect in sepsis

  • It is generally inferred that increased circulating cortisol during critical illness is a consequence of increased HPA axis activity and increased levels of ACTH, ACTH levels have been found at similar levels or even below those of healthy controls [4,5,6]

  • Bergquist et al Intensive Care Medicine Experimental (2015) 3:23. These findings suggest that rather than an increased production of cortisol, elevated cortisol levels are a consequence of a dysfunctional cortisol clearance from circulation which results in the supranormal cortisol levels found in the critically ill patients

Read more

Summary

Introduction

Glucocorticoid (GC) treatment has variable effect in sepsis. This may be explained by decreased expression or function of the glucocorticoid receptor (GR). The expression and activity of A-ring reductases (the principal route of cortisol breakdown in humans) and 11β-HSD type 2 (converting cortisol to cortisone, inert to cells) were found reduced in the liver but not in the adipose tissue [6] This raises the question whether the glucocorticoid receptor has a decreased expression or function during critical illness. To the best of our knowledge, the effect of human sepsis on GR protein expression and GR binding capacity has not been investigated previously The aim of this explorative, observational study was to describe GR expression and binding capacity in circulating T lymphocytes and neutrophils, sampled from peripheral blood of adults during septic shock and after recovery

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call